How to Engage Employed Physicians
Happy doctors make happy patients, just like happy employees anywhere make happy customers.
Menthol Cigarettes Ban Delayed
The Food and Drug Administration (FDA) has once again delayed the ban on menthol cigarettes, a move that has sparked ...
Medicaid Plan That Booted Patients Nets Profit
Private Medicaid health plans lost millions of members in the past year as pandemic protections that prohibited states from dropping ...
Implicit Bias Training in Medicine is Still Lacking
There is increasing evidence that implicit bias is a source of racial inequities in certain aspects of health care, and ...
Debunking Latest Round of COVID Misinformation
With the pandemic still raging on, it's crucial to separate fact from fiction and make informed decisions about our health ...
Do We Have Enough H5N1 Vaccines?
In the face of a potential H5N1 bird flu pandemic, the world is woefully unprepared not only in terms of ...
Health Algorithms Risk Price Fixing
Algorithms make it possible for companies to fix prices without explicitly coordinating with one another, posing a new test for ...
Weight Loss Injections Popularize Compound Pharmacies
In recent years, the prevalence of obesity has reached alarming levels worldwide, leading to a surge in demand for effective ...
How To Navigate Loss of Mobility From a Spinal Cord Injury
Losing the ability to move freely because of a spinal cord injury is incredibly challenging to experience. Here are tips ...
No Clinical Basis for MMEs
MME represents junk science and the CDC 2016 and 2022 guidelines on prescription of opioids to adults with chronic non-cancer ...
The “Old” Days of Medical Practice
A woman in her 70s reacted to one of my online essays about the importance of narrative medicine to physicians’ ...
What Do Russian Rocket Scientists and American Doctors Have in Common?
Why are so many doctors suddenly being prosecuted by the federal government? Did doctors change their practice habits or did ...
FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation
Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read morePopular
-
The IRA’s Drug Negotiation Mechanism Meets the Rebate Industrial Complex
-
Growth Hormone Secretagogues and the Longevity Trade-Off
-
Retatrutide: The Weight Loss Drug Everyone Wants—But Can’t Officially Get
-
The Second Reader That Never Sleeps: Large Language Models and Clinical Decision-Making
-
GLP-1 Agonists Beyond Obesity: The Expanding Therapeutic and Optimization Frontier
